Shareholders say directors of NRG Energy unreasonably rejected a $6.2 billion buyout offer from Exelon - 0.485 Exelon shares for each NRG share - in Delaware Chancery Court.
Shareholders sued Omrix Pharmaceuticals in New York County Court, seeking to enjoin its acquisition by Johnson & Johnson.
Directors of Transmeta Corp. unfairly capped the stock price in Novafora's $255 million buyout offer, shareholders say in Santa Clara County Court, Calif.
Reserve Management Co. inflated the price of its Reserve Short-Term Trust and Reserve Yield Plus mutual funds through false and misleading statements, shareholders claim in Manhattan Federal Court.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.